M&T Bank Corp Edwards Lifesciences Corp Transaction History

M&T Bank Corp

$28.6 Billion
Q1 2024

A detailed history of M&T Bank Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, M&T Bank Corp holds 66,160 shares of EW stock, worth $6.11 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

66,160

Previous 71,727 7.76%

Holding current value

$6.11 Million

Previous $5.47 Million 15.6%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$72.54 - $95.56 $403,830 - $531,982	-5,567 Reduced 7.76%	66,160 $6.32 Million
Q4 2023 Feb 06, 2024	SELL	$61.71 - $77.76 $1.8 Million - $2.27 Million	-29,194 Reduced 28.93%	71,727 $5.47 Million
Q3 2023 Nov 02, 2023	SELL	$69.28 - $93.38 $1.83 Million - $2.46 Million	-26,357 Reduced 20.71%	100,921 $6.99 Million
Q2 2023 Aug 09, 2023	SELL	$81.41 - $94.33 $570,765 - $661,347	-7,011 Reduced 5.22%	127,278 $12 Million
Q1 2023 May 11, 2023	SELL	$74.26 - $84.51 $363,874 - $414,099	-4,900 Reduced 3.52%	134,289 $11.1 Million

Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $960,981 - $1.23 Million	-14,070 Reduced 9.36%	136,200 $10.2 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $204,148 - $261,358	2,989 Added 2.19%	139,189 $10.4 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $6.54 Million - $8.51 Million	-79,357 Reduced 34.56%	150,270 $11.1 Million
Q2 2022 Aug 05, 2022	BUY	$86.5 - $128.27 $14.3 Million - $21.2 Million	165,045 Added 255.56%	229,627 $10.6 Million
Q1 2022 May 09, 2022	BUY	$101.96 - $128.34 $364,507 - $458,815	3,575 Added 5.86%	64,582 $7.6 Million
Q4 2021 Feb 07, 2022	BUY	$106.37 - $130.68 $125,516 - $154,202	1,180 Added 1.97%	61,007 $7.9 Million
Q3 2021 Oct 28, 2021	SELL	$102.91 - $122.75 $430,781 - $513,831	-4,186 Reduced 6.54%	59,827 $6.77 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $147,139 - $183,853	-1,755 Reduced 2.67%	64,013 $6.63 Million
Q1 2021 May 06, 2021	SELL	$78.68 - $90.67 $1.57 Million - $1.81 Million	-19,910 Reduced 23.24%	65,768 $5.5 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $64,807 - $82,471	904 Added 1.07%	85,678 $7.82 Million
Q3 2020 Nov 06, 2020	SELL	$67.19 - $87.44 $96,014 - $124,951	-1,429 Reduced 1.66%	84,774 $6.77 Million
Q2 2020 Jul 29, 2020	BUY	$57.54 - $76.95 $3.24 Million - $4.34 Million	56,378 Added 189.03%	86,203 $5.96 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $13,836 - $21,384	264 Added 0.89%	29,825 $5.63 Million
Q4 2019 Feb 07, 2020	SELL	$71.7 - $82.09 $280,992 - $321,710	-3,919 Reduced 11.71%	29,561 $6.9 Million
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $23,265 - $28,512	-378 Reduced 1.12%	33,480 $7.36 Million
Q2 2019 Aug 12, 2019	SELL	$55.74 - $64.41 $109,529 - $126,565	-1,965 Reduced 5.49%	33,858 $6.25 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $79,353 - $106,130	-1,657 Reduced 4.42%	35,823 $6.86 Million
Q4 2018 Feb 01, 2019	SELL	$46.41 - $56.94 $76,854 - $94,292	-1,656 Reduced 4.23%	37,480 $5.74 Million
Q3 2018 Nov 09, 2018	BUY	$45.7 - $58.03 $163,743 - $207,921	3,583 Added 10.08%	39,136 $6.81 Million
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $6,792 - $8,208	160 Added 0.45%	35,553 $5.18 Million
Q1 2018 May 04, 2018	SELL	$37.19 - $47.45 $83,603 - $106,667	-2,248 Reduced 5.97%	35,393 $4.94 Million
Q4 2017 Feb 06, 2018	SELL	$33.79 - $39.39 $21,084 - $24,579	-624 Reduced 1.63%	37,641 $4.24 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $246,191 - $263,422	6,784 Added 21.55%	38,265 $4.18 Million
Q2 2017 Aug 11, 2017	BUY	N/A	31,481	31,481 $3.72 Million

Others Institutions Holding EW

# of Institutions

1,375

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account